Allakos Inc (ALLK)

Allakos Inc 주식(ALLK)의 최신 뉴스

Allakos Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire Inc.

Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions

Zacks Investment Research

Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire Inc.

Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024

GlobeNewswire Inc.

Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition

GlobeNewswire Inc.

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Zacks Investment Research

Allakos (ALLK) Plummets 60% on Ending Development of Lead Drug

Zacks Investment Research

Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday

Benzinga

Gold Down 1%; PNC Financial Posts Upbeat Earnings

Benzinga

Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue

Benzinga

Dow Dips 200 Points; Goldman Sachs Earnings Top Views

Benzinga

Is Allakos (ALLK) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research

Allakos Announces a Restructuring to Focus on Development of AK006

GlobeNewswire Inc.

Street Calls of the Week: Pepsi may fizzle out

Investing.com

Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive

Benzinga

Where Allakos Stands With Analysts

Benzinga

What 4 Analyst Ratings Have To Say About Allakos

Benzinga